Corcept therapeutics inc (CORT)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Product revenue, net

334,904

306,486

285,422

268,362

258,417

251,247

237,696

216,014

189,261

159,201

129,732

108,694

92,859

81,321

72,477

64,013

56,245

50,286

44,332

38,353

32,248

26,551

21,653

17,005

13,045

10,357

7,619

6,040

5,024

3,307

0

0

0

-

-

-

-

-

-

Operating expenses:
Cost of sales

6,142

5,504

5,647

5,504

5,281

5,215

4,793

4,461

4,082

3,554

2,958

2,650

2,301

2,058

1,861

1,449

1,462

1,361

1,255

1,234

1,010

882

684

489

297

143

102

86

111

91

0

0

0

-

-

-

-

-

-

Research and development

94,896

89,017

83,499

79,554

78,441

75,247

70,084

62,917

50,250

40,376

33,229

28,590

26,386

23,844

21,449

18,007

15,676

15,419

15,118

14,553

15,464

18,372

21,151

23,259

23,498

20,470

18,759

16,612

14,789

14,074

15,864

16,084

19,619

21,001

19,579

20,925

0

0

0

Selling, general and administrative

103,505

100,359

94,785

91,848

87,238

81,289

76,524

71,687

65,819

62,416

57,380

51,840

49,845

45,240

42,344

40,704

37,928

36,949

36,129

35,941

34,564

34,916

34,391

32,467

32,662

31,240

30,204

28,719

26,310

25,414

22,214

19,729

16,644

11,331

9,930

8,592

0

0

0

Total operating expenses

204,543

194,880

183,931

176,906

170,960

161,751

151,401

139,065

120,151

106,346

93,567

83,080

78,532

71,142

65,654

60,160

55,066

53,729

52,502

51,728

51,038

54,170

56,226

56,215

56,457

51,853

49,065

45,417

41,210

39,579

38,150

35,861

36,263

32,332

29,509

29,517

0

0

0

Income from operations

130,361

111,606

101,491

91,456

87,457

89,496

86,295

76,949

69,110

52,855

36,165

25,614

14,327

10,179

6,823

3,853

1,179

-3,443

-8,170

-13,375

-18,790

-27,619

-34,573

-39,210

-43,412

-41,496

-41,446

-39,377

-36,186

-36,272

-36,220

-34,986

-36,263

-32,332

-29,509

-29,517

0

0

0

Interest and other income

5,444

5,070

4,665

4,076

3,460

2,657

1,803

1,130

470

-49

-2,931

-3,504

-2,875

-2,039

-4,583

-3,393

-3,154

-2,965

3,092

3,292

3,493

3,764

4,039

4,302

4,445

4,515

4,565

4,021

2,912

1,776

639

18

25

25

21

23

0

0

0

Interest and other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

8

758

0

0

0

Income before income taxes

135,805

116,676

106,156

95,532

90,917

92,153

88,098

78,079

69,580

52,806

35,518

24,394

12,674

8,140

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

29,795

22,495

19,313

17,313

14,713

16,743

-63,615

-69,663

-72,613

-76,316

129

177

127

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income

105,972

94,181

86,808

78,215

76,225

75,410

151,732

147,742

142,193

129,122

35,389

24,217

12,547

8,140

4,502

1,316

-1,597

-6,408

-11,262

-16,667

-22,283

-31,383

-38,612

-43,512

-47,857

-46,011

-46,011

-43,398

-39,098

-38,048

-36,860

-35,002

-36,287

-32,354

-29,522

-28,782

0

0

0

Other comprehensive income (loss):
Net unrealized gain on available-for-sale investments, net of tax impact of $(20) and $(52), respectively

224

327

471

523

321

5

-138

-185

-215

-75

-14

-17

-12

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Foreign currency translation loss, net of tax

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total comprehensive income

106,188

94,512

87,274

78,738

76,546

75,415

151,594

147,557

141,978

129,047

35,375

24,200

12,535

8,140

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net income per share (in dollars per share)

0.26

0.25

0.23

0.18

0.16

0.19

0.15

0.16

0.15

0.87

0.12

0.11

0.04

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income per share (in dollars per share)

0.25

0.23

0.22

0.17

0.15

0.18

0.14

0.14

0.14

0.79

0.11

0.10

0.04

-

0.02

0.01

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per common share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-0.01

-0.02

-0.05

-0.04

-0.06

-0.07

-0.14

-0.11

-0.11

-0.12

-0.12

-0.11

-0.08

-0.09

-0.13

-0.11

-0.08

-0.11

-0.09

-0.10

-0.09

Weighted-average shares outstanding used in computing net income per share
Basic (in shares)

114,575

114,337

113,875

114,340

114,844

115,200

115,798

115,492

114,882

114,389

113,603

113,249

112,867

111,917

110,652

110,034

109,661

-

108,461

107,874

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

122,226

122,824

121,762

121,783

123,895

125,345

126,159

127,515

127,733

128,209

125,651

123,011

121,189

123,147

116,419

115,329

109,661

-

108,461

107,874

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares outstanding used in computing basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

101,905

-

101,134

100,980

100,521

99,834

99,814

99,814

99,814

99,937

99,082

88,621

84,420

84,274

84,188

84,010

80,764

72,045

66,142